AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 87, Issue 12 2014-2017, Copyright © 1997 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buchanan, R J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buchanan, R J
Compliance with tuberculosis drug regimens: incentives and enablers offered by public health departments.

R J Buchanan

Department of Community Health, University of Illinois at Urbana-Champaign, USA.

OBJECTIVES: This research examined incentives implemented by public health departments to encourage tuberculosis patients to comply with tuberculosis drug regimens. METHODS: A questionnaire addressing incentives was mailed to the directors of each state's health department during May 1995. All 50 states and the District of Columbia returned questionnaires. RESULTS: The survey results indicate that public health departments in almost all states are implementing the incentives advocated by tuberculosis experts. CONCLUSIONS: The implementation of these incentives may help to explain why the incidence of tuberculosis resumed its long-term decline in the United States during 1993 after a decade of resurgence.




This article has been cited by other articles:


Home page
JOURNAL OF CORRECTIONAL HEALTH CAREHome page
M. C. White, S. Cuttler, and Xin Zhao
Linking Released Inmates to TB Clinic for Treatment of Latent Tuberculosis Infection: Why Is it so Difficult?
Journal of Correctional Health Care, July 1, 2007; 13(3): 206 - 215.
[Abstract] [PDF]


Home page
ChestHome page
M. N. Lobato, R. R. Reves, R. M. Jasmer, J. C. Grabau, N. N. Bock, N. Shang, and for the 2RZ Study Group
Adverse Events and Treatment Completion for Latent Tuberculosis in Jail Inmates and Homeless Persons
Chest, April 1, 2005; 127(4): 1296 - 1303.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. C. White, J. P. Tulsky, J. Goldenson, C. J. Portillo, M. Kawamura, and E. Menendez
Randomized Controlled Trial of Interventions to Improve Follow-up for Latent Tuberculosis Infection After Release From Jail
Arch Intern Med, May 13, 2002; 162(9): 1044 - 1050.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. V. Brooks and I. M. Orme
Evaluation of Once-Weekly Therapy for Tuberculosis Using Isoniazid plus Rifamycins in the Mouse Aerosol Infection Model
Antimicrob. Agents Chemother., November 1, 1998; 42(11): 3047 - 3048.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Public Health Association